Results 251 to 260 of about 208,282 (274)

How Effective Are the Canine Visceral Leishmaniasis Vaccines Currently Being Tested in Dogs? A Systematic Review and Meta-Analysis. [PDF]

Parasite Immunol
de Pádua JAM, Melo TF, Andrade RS, de Oliveira MM, de Oliveira ALG, Saldanha-Elias AM, Fujiwara RT, Dorneles EMS, Peconick AP, Keller KM.   +9 more
europepmc   +1 more source

Visceral leishmaniasis related secondary haemophagocytic syndrome: A case report. [PDF]

J Int Med Res
Chen C, Yu Y, Zhu Ma LZ, Nin J, Zhang D, Nong W, Pan X.   +6 more
europepmc   +1 more source

Characterization of a novel <i>Leishmania</i> antigen containing a repetitive domain and its potential use as a prophylactic and therapeutic vaccine. [PDF]

mSphere
de Oliveira B, Goes WM, Nascimento FC, Carnielli JBT, Ferreira ER, de Carvalho AF, Dos Reis PVM, Pereira M, Ricotta TQN, Dos Santos LM, de Souza RP, Cargnelutti DE, Mottram JC, Teixeira SR, Fernandes AP, Gazzinelli RT.   +15 more
europepmc   +1 more source

Discrepancies in neglected tropical diseases burden estimates in China: comparative study of real-world data and Global Burden of Disease 2021 data (2004-2020).

BMJ
Yang GJ, Ouyang HQ, Zhao ZY, Li WH, Fall IS, Djirmay AG, Zhou XN.   +6 more
europepmc   +1 more source

Assessment of nutritional status among post-kala-azar dermal leishmaniasis patients in endemic areas of northern West Bengal, India.

Trop Parasitol
Samanta A, Patra D, Chaudhury A, Saha P, Sardar AA, Halder S, Maji AK, Guha SK, Das S.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Efficacy and safety of Pentamidine isethionate for tegumentary and visceral human leishmaniasis: a systematic review.

Journal of Travel Medicine, 2021
RATIONALE FOR REVIEW We performed a systematic review of the literature to investigate the efficacy and safety of pentamidine isethionate for the treatment of human visceral and tegumentary leishmaniasis.
Matteo Piccica, F. Lagi, A. Bartoloni, L. Zammarchi   +3 more
semanticscholar   +1 more source

Visceral Leishmaniasis

New England Journal of Medicine, 2019
Visceral Leishmaniasis ...
Loscocco G. G, Piccini M.
openaire   +2 more sources

VISCERAL LEISHMANIASIS

Gastroenterology Clinics of North America, 1996
Visceral leishmaniasis presents a serious problem in endemic regions that is difficult to treat or prevent. Several epidemiologic problems make the disease particularly troublesome to manage. These include the facts that classic visceral leishmaniasis is fatal if untreated and there is not reliable access to medical care in many endemic regions.
M E, Wilson, J A, Streit
openaire   +2 more sources

Visceral leishmaniasis in paediatrics

Current Opinion in Infectious Diseases, 2002
Visceral leishmaniasis is a vector-borne systemic infection, which affects half a million people each year in many areas of the world. Typical disease manifests with fever, hepatosplenomegaly, pancytopenia, and progressive deterioration of the host. Although molecular methods appear promising as a non-invasive diagnostic tool, definite diagnosis still ...
Dimitris A. Kafetzis, Helen C. Maltezou
openaire   +2 more sources